AZANTA A/S: Financial statements 2024
CVR: 28108915
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
AZANTA A/S (CVR 28108915) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 536,000 and a net result of DKK 21,695,000 compared with DKK 13,615,000 the year before. Equity in the 2024 report amounted to DKK 261,616,000. The solvency ratio was 77.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 536,000
- Profit/Loss
- DKK 21,695,000
- Equity
- DKK 261,616,000
- Total Assets
- DKK 337,626,000
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 536K | 21.7M | 261.6M | 1 |
| 2023 | - | -579K | 13.6M | 239.9M | 1 |
| 2022 | - | -9.8M | 16.3M | 226.2M | 2 |
| 2021 | - | 4.7M | 19.9M | 210M | 2 |
| 2020 | - | 9.4M | 166.2M | 190.2M | 3 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
AZANTA A/S has published its annual report for 2023. Gross profit came to DKK -579,000, and the net result was DKK 13,615,000.
About AZANTA A/S
AZANTA A/S is a Danish company of the type Aktieselskab based in Valby, founded in 2004. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named IPC INTERNATIONAL A/S and IPC PHARMA A/S. The management consists of Erik Niklas Eriksson. The board consists of Ina Høydal Helle (chair), Erik Niklas Eriksson and Laura Elizabeth Barrell. The company is owned by Norgine B.V.. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 2,135,000 and a net result of DKK 40,581,000 compared with DKK 21,695,000 the year before. Equity in the 2025 report amounted to DKK 302,123,000.